Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333–366
PubMed
CrossRef
CAS
Google Scholar
Ecroyd H, Carver JA (2008) Unraveling the mysteries of protein folding and misfolding. IUBMB Life 60:769–774
PubMed
CrossRef
CAS
Google Scholar
Jiménez JL, Nettleton EJ, Bouchard M, Robinson CV, Dobson CM, Saibil HR (2002) The protofilament structure of insulin amyloid fibrils. Proc Natl Acad Sci USA 99:9196–9201
PubMed
CrossRef
Google Scholar
Fowler DM, Koulov AV, Balch WE, Kelly JW (2007) Functional amyloid—from bacteria to humans. Trends Biochem Sci 32:217–224
PubMed
CrossRef
CAS
Google Scholar
Garvey M, Gras SL, Meehan S, Meade SJ, Carver JA, Gerrard JA (2009) Protein nanofibres of defined morphology prepared from mixtures of crude crystallins. Int J Nanotech 6:258–273
CrossRef
CAS
Google Scholar
Gras SL (2007) Amyloid fibrils: From disease to design. New biomaterial applications for self-assembling cross beta-fibrils. Aust J Chem 60:333–342
CrossRef
CAS
Google Scholar
Cherny I, Gazit E (2008) Amyloids: not only pathological agents but also ordered nanomaterials. Angew Chem Int Ed Engl 47:4062–4069
PubMed
CrossRef
CAS
Google Scholar
Bloemendal H, de Jong W, Jaenicke R, Lubsen NH, Slingsby C, Tardieu A (2004) Ageing and vision: structure, stability and function of lens crystallins. Prog Biophys Mol Biol 86:407–485
PubMed
CrossRef
CAS
Google Scholar
Meehan S, Berry Y, Luisi B, Dobson CM, Carver JA, MacPhee CE (2004) Amyloid fibril formation by lens crystallin proteins and its implications for cataract formation. J Biol Chem 279:3413–3419
PubMed
CrossRef
CAS
Google Scholar
Meehan S, Knowles TP, Baldwin AJ, Smith JF, Squires AM, Clements P, Treweek TM, Ecroyd H, Tartaglia GG, Vendruscolo M, Macphee CE, Dobson CM, Carver JA (2007) Characterisation of amyloid fibril formation by small heat-shock chaperone proteins human alphaA-, alphaB- and R120G alphaB-crystallins. J Mol Biol 372:470–484
PubMed
CrossRef
CAS
Google Scholar
Horwitz J, Huang QL, Ding L, Bova MP (1998) Lens alpha-crystallin: chaperone-like properties. Methods Enzymol 290:365–383
PubMed
CrossRef
CAS
Google Scholar
Thorn DC, Ecroyd H, Carver JA (2009) The two-faced nature of milk casein proteins: amyloid fibril formation and chaperone-like activity. Aust J Dairy Technol 64:36–40
Google Scholar
Thorn DC, Ecroyd H, Sunde M, Poon S, Carver JA (2008) Amyloid fibril formation by bovine milk alphaS2-casein occurs under physiological conditions yet is prevented by its natural counterpart, alphaS1-casein. Biochemistry 47:3926–3936
PubMed
CrossRef
CAS
Google Scholar
Thorn DC, Meehan S, Sunde M, Rekas A, Gras SL, MacPhee CE, Dobson CM, Wilson MR, Carver JA (2005) Amyloid fibril formation by bovine milk kappa-casein and its inhibition by the molecular chaperones alpha(S)- and beta-casein. Biochemistry 44:17027–17036
PubMed
CrossRef
CAS
Google Scholar
Morgan PE, Treweek TM, Lindner RA, Price WE, Carver JA (2005) Casein proteins as molecular chaperones. J Agric Food Chem 53:2670–2683
PubMed
CrossRef
CAS
Google Scholar
Ecroyd H, Thorn DC, Liu Y, Carver JA (2010) The dissociated form of kappa-casein is the precursor to its amyloid fibril formation. Biochem J 429:251–260
PubMed
CrossRef
CAS
Google Scholar
Ecroyd H, Koudelka T, Thorn DC, Williams DM, Devlin G, Hoffmann P, Carver JA (2008) Dissociation from the oligomeric state is the rate-limiting step in amyloid fibril formation by kappa-casein. J Biol Chem 283:9012–9022
PubMed
CrossRef
CAS
Google Scholar
Carver JA, Duggan PJ, Ecroyd H, Liu Y, Meyer AG, Tranberg CE (2010) Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation. Bioorg Med Chem 18:222–228
PubMed
CrossRef
CAS
Google Scholar